臨床試驗

Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

NCT：NCT05557123 · COMPLETED

NCT IDNCT05557123

狀態COMPLETED

開始日期2022-03-10

完成時間2025-12-16

SponsorSeoul National University Bundang Hospital (OTHER)

First posted2022-09-27

Last updated2026-05-19

簡要摘要

RIVOX-AF study is a prospective, multicenter, randomized controlled study in which patients with AF are allocated to medication-app group or conventional treatment group. The App based feed-back algorithm will provide the patients with check taking drug or reminding of taking drug.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。